Michael Robert Martin - 28 Jul 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Business Officer
Signature
/s/ Michael Robert Martin
Issuer symbol
AUPH
Transactions as of
28 Jul 2021
Net transactions value
-$69,300
Form type
4
Filing time
29 Jul 2021, 16:09:42 UTC
Previous filing
23 Jun 2021
Next filing
10 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale $69,300 -5,000 -2.3% $13.86 211,861 28 Jul 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2021.
F2 Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the sold date.
F3 The price in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.